<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000739.v1.p1" parentStudy="phs000739.v1.p1" createDate="2014-04-17" modDate="2014-04-18">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Robert West, MD, PhD</td><td>Stanford School of Medicine, Department of Pathology, Stanford, CA USA</td></tr>
		<tr><td>Principal Investigator</td><td>Jonathan Pollack, MD</td><td>Stanford School of Medicine, Department of Pathology, Stanford, CA USA</td></tr>
		<tr><td>Principal Investigator</td><td>Philip Beachy, PhD</td><td>Stanford School of Medicine, Departments of Biochemistry and Developmental Biology, Stanford, CA, USA</td></tr>
		<tr><td>Funding Source</td><td>Stanford Department of Pathology</td><td>Stanford School of Medicine, Department of Pathology, Stanford, CA USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Identification of Recurrent SMO and BRAF Mutations in Ameloblastomas</StudyNameEntrez>
	<StudyNameReportPage>Identification of Recurrent SMO and BRAF Mutations in Ameloblastomas</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Cohort</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>RNA-seq data from two cases of ameloblastoma was analyzed for candidate gene fusions and point mutations. Recurrent point mutations identified in the RNA-seq data, as well as mutations identified with limited panel targeted deep sequencing, were validated as somatic. Expanding to a larger cohort of 28, one of two activating mutations was found in 80% of cases. No recurrent gene fusions events were identified.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Cases of ameloblastoma were selected from the pathology archives. The diagnosis was confirmed. Exclusion criteria was documentation that the material had been subjected to decalcification for tissue processing because the decalcification solution severely degrades nucleic acids.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="13707265"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24374844"/>
		</Publication>
		<Publication>
			<Pubmed pmid="15128061"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Ameloblastoma"/>
		<Disease vocab_source="MESH" vocab_term="SMO protein, human"/>
		<Disease vocab_source="MESH" vocab_term="BRAF protein, human"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Robert West, MD, PhD</AttName>
			<Institution>Stanford School of Medicine, Department of Pathology, Stanford, CA USA</Institution>
		</Header>
		<Header title="Principal Investigator">
			<AttName>Jonathan Pollack, MD</AttName>
			<Institution>Stanford School of Medicine, Department of Pathology, Stanford, CA USA</Institution>
		</Header>
		<Header title="Principal Investigator">
			<AttName>Philip Beachy, PhD</AttName>
			<Institution>Stanford School of Medicine, Departments of Biochemistry and Developmental Biology, Stanford, CA, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>Stanford Department of Pathology</AttName>
			<Institution>Stanford School of Medicine, Department of Pathology, Stanford, CA USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="GRU-MDS" longName="General Research Use (MDS)"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NCI</DacName>
      <DacFullName>NCI</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000739.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000739.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000739.v1.p1" FileName="eNCI_0190_DUC_4.14.14.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use (MDS)</ConsentName>
        <ConsentAbbrev>GRU-MDS</ConsentAbbrev>
        <UseLimitation>Use of the data is limited only by the terms of the model Data Use Certification.
Use of the data includes methods development research (e.g., development of software or algorithms).</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
